Hong Kong firms eye Chinese medicine opportunities on the mainland: HKTDC

scmp.com/business/article/3319483/hong-kong-firms-eye-proprietary-chinese-medicine-opportunities-mainland-hktdc

Beijing’s move to simplify the process for approving oral proprietary Chinese medicine (PCM) from Hong Kong to be sold across the border has created new opportunities for firms in the city to exploit the mainland’s 450 billion yuan (US$62.8 billion) market, according to Hong Kong’s trade…

This story appeared on scmp.com, 2025-07-24 12:30:15.
The Entire Business World on a Single Page. Free to Use →